HEADER ANTIBIOTIC 19-NOV-99 1QOW TITLE MERSACIDIN FROM BACILLUS COMPND MOL_ID: 1; COMPND 2 MOLECULE: MERSACIDIN; COMPND 3 CHAIN: A, B, C, D, E, F SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS SP.; SOURCE 3 ORGANISM_TAXID: 1409; SOURCE 4 STRAIN: HIL Y-85, 54728 KEYWDS LANTIBIOTIC, ANTIBIOTIC, METHICILLIN RESISTANCE, THIOESTER, TYPE B KEYWDS 2 LANTIBIOTIC, LANTHIONINE EXPDTA X-RAY DIFFRACTION AUTHOR T.R.SCHNEIDER,J.KAERCHER,G.M.SHELDRICK REVDAT 8 09-OCT-19 1QOW 1 JRNL REVDAT 7 24-JUL-19 1QOW 1 REMARK REVDAT 6 22-MAY-19 1QOW 1 REMARK REVDAT 5 17-APR-19 1QOW 1 REMARK LINK REVDAT 4 27-JUL-11 1QOW 1 REVDAT REMARK SITE HETATM REVDAT 4 2 1 ANISOU REVDAT 3 13-JUL-11 1QOW 1 VERSN REVDAT 2 24-FEB-09 1QOW 1 VERSN REVDAT 1 26-MAY-00 1QOW 0 JRNL AUTH T.R.SCHNEIDER,J.KARCHER,E.POHL,P.LUBINI,G.M.SHELDRICK JRNL TITL AB INITIO STRUCTURE DETERMINATION OF THE LANTIBIOTIC JRNL TITL 2 MERSACIDIN. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 56 705 2000 JRNL REFN ISSN 0907-4449 JRNL PMID 10818347 JRNL DOI 10.1107/S0907444900003711 REMARK 2 REMARK 2 RESOLUTION. 1.06 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.06 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.141 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.141 REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 33449 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.134 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 29862 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 750 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 18 REMARK 3 SOLVENT ATOMS : 57 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 826.00 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 719.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 7438 REMARK 3 NUMBER OF RESTRAINTS : 10782 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 ANGLE DISTANCES (A) : 0.034 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.017 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.027 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.069 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.061 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.016 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.005 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.052 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.068 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-2 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: SIMILARITY RESTRAINTS FOR NON-STANDARD RESIDUES AS REMARK 3 IMPLEMENTED IN SHELXL97 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: MEROHEDRAL TWINNING: THE CRYSTAL WAS REMARK 3 MEROHEDRALLY TWINNED. THE EFFECT OF MEROHEDRAL WAS TAKEN INTO REMARK 3 ACCOUNT EMPLOYING THE METHOD OF PRATT ET AL., J.CHEM.SOC.(A) REMARK 3 (1971)2146-2151 AND JAMESON ET AL., ACTA CRYST.B54 (1982)443-449 REMARK 3 AS IMPLEMENTED IN SHELXL-97 USING THE TWIN MATRIX: (0 1 0 1 0 0 REMARK 3 0 0 -1). THE SIX MOLECULES IN THE ASYMMETRIC UNIT ARE ARRANGED REMARK 3 WITH APPROXIMATE 32 (D3) POINT GROUP SYMMETRY AND CAN BE REMARK 3 DESCRIBED AS A DIMER OF TRIMERS. THE TWO FOLD AXIS RUNS ALONG REMARK 3 THE SHORT DIAGONAL OF THE A*B* PLANE. REMARK 4 REMARK 4 1QOW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-NOV-99. REMARK 100 THE DEPOSITION ID IS D_1290004404. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-94 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.865 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33469 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.060 REMARK 200 RESOLUTION RANGE LOW (A) : 39.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.06 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.36400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: HALF-BAKED REMARK 200 SOFTWARE USED: SHELXL-97 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 28.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: LYOPHILIZED MERSACIDIN WAS DISSOLVED REMARK 280 TO SATURATION IN METHANOL. CRYSTALS GREW AT ROOM TEMPERATURE BY REMARK 280 SLOW EVAPORATION OF METHANOL FROM A 1:1 MIXTURE OF THE SATURATED REMARK 280 SOLUTION WITH BENZENE AND REACHED A MAXIMUM SIZE OF 0.3 X 0.3 X REMARK 280 0.3 MM IN 10 DAYS., PH 7.00, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 20.68000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 10.34000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6040 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -70.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 MERSACIDIN IS A GLOBULAR TYPE B LANTIBIOTIC. THE LANTIBIOTICS REMARK 400 ARE CHARACTERIZED BY LANTHIONINE AND/OR METHYLLANTHIONINE REMARK 400 NONPROTEINOGENIC AMINO ACIDS. REMARK 400 HERE, MERSACIDIN IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: MERSACIDIN REMARK 400 CHAIN: A, B, C, D, E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 20 REMARK 400 DESCRIPTION: MERSACIDIN IS A TETRACYCLIC PEPTIDE. THIOETHER REMARK 400 BONDS WITH CYSTEINE RESULT IN FOUR RINGS. REMARK 400 CROSSLINK 1-4 BETA-METHYLLANTHIONINE (CYS-DBB) REMARK 400 CROSSLINK 4-12 BETA-METHYLLANTHIONINE (DBB-CYS) REMARK 400 CROSSLINK 13-18 BETA-METHYLLANTHIONINE (DBB-CYS) REMARK 400 CROSSLINK 15-20 S-(2-AMINOVINYL)-3-METHYL-D- REMARK 400 CYSTEINE (DBB-TEE) REMARK 400 REMARK 400 THE MERSACIDIN IS OLIGOPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: MERSACIDIN REMARK 400 CHAIN: A, B, C, D, E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: MERSACIDIN IS A TETRACYCLIC PEPTIDE. POST REMARK 400 TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES REMARK 400 THE ENZYMIC CONVERSION OF THR, AND SER INTO REMARK 400 DEHYDRATED AA AND THE FORMATION OF THIOETHER BONDS REMARK 400 WITH CYSTEINE. THE CARBOXY-TERMINAL BETA- REMARK 400 METHYLLANTHIONINE UNDERGOES DECARBOXYLATION. REMARK 400 THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS. REMARK 400 THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND REMARK 400 CLEAVAGE OF THE MODIFIED PRECURSOR. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 18 CB - CA - C ANGL. DEV. = 7.3 DEGREES REMARK 500 LEU D 5 CA - CB - CG ANGL. DEV. = 14.8 DEGREES REMARK 500 GLU E 17 OE1 - CD - OE2 ANGL. DEV. = -9.6 DEGREES REMARK 500 ILE E 19 CA - CB - CG1 ANGL. DEV. = 18.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 DBB A 2 -168.61 -68.23 REMARK 500 LEU A 5 71.05 -119.50 REMARK 500 CYS A 18 -132.24 -110.67 REMARK 500 DBB B 2 -169.43 -66.75 REMARK 500 CYS B 18 -125.88 -112.08 REMARK 500 DBB C 2 -168.56 -69.77 REMARK 500 CYS C 18 -124.66 -112.91 REMARK 500 DBB D 2 -166.43 -69.10 REMARK 500 CYS D 18 -127.38 -105.27 REMARK 500 DBB E 2 -168.89 -71.21 REMARK 500 CYS E 18 -127.25 -109.87 REMARK 500 DBB F 2 -167.18 -68.11 REMARK 500 CYS F 18 -122.16 -110.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN A OF MERSACIDIN REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF MERSACIDIN REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF MERSACIDIN REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF MERSACIDIN REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF MERSACIDIN REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF MERSACIDIN REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AJ1 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE LANTIBIOTIC ACTAGARDINE REMARK 900 RELATED ID: 1MQX RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN IN MEOH/H2O REMARK 900 MIXTURE REMARK 900 RELATED ID: 1MQY RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN IN DPC MICELLES REMARK 900 RELATED ID: 1MQZ RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN BOUND TO LIPID REMARK 900 II IN DPC MICELLES REMARK 900 RELATED ID: 1W9N RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE LANTIBIOTIC EPILANCIN 15X REMARK 900 RELATED ID: 1WCO RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF NISIN AND LIPID II COMPLEX REMARK 900 RELATED ID: 2DDE RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE LANTIBIOTIC CINNAMYCIN COMPLEXED WITH REMARK 900 LYSOPHOSPHATIDYLETHANOLAMINE REMARK 900 RELATED ID: 2KTN RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF LCH-ALPHA PEPTIDE FROM TWO-COMPONENT REMARK 900 LANTIBIOTIC SYSTEM LICHENICIDIN VK21 A1 REMARK 900 RELATED ID: 2KTO RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF LCH-BETA PEPTIDE FROM TWO-COMPONENT REMARK 900 LANTIBIOTIC LICHENICIDIN VK21 A2 DBREF 1QOW A 1 20 UNP P43683 MRSA_BACSP 49 68 DBREF 1QOW B 1 20 UNP P43683 MRSA_BACSP 49 68 DBREF 1QOW C 1 20 UNP P43683 MRSA_BACSP 49 68 DBREF 1QOW D 1 20 UNP P43683 MRSA_BACSP 49 68 DBREF 1QOW E 1 20 UNP P43683 MRSA_BACSP 49 68 DBREF 1QOW F 1 20 UNP P43683 MRSA_BACSP 49 68 SEQRES 1 A 20 CYS DBB PHE DBB LEU PRO GLY GLY GLY GLY VAL CYS DBB SEQRES 2 A 20 LEU DBB DHA GLU CYS ILE TEE SEQRES 1 B 20 CYS DBB PHE DBB LEU PRO GLY GLY GLY GLY VAL CYS DBB SEQRES 2 B 20 LEU DBB DHA GLU CYS ILE TEE SEQRES 1 C 20 CYS DBB PHE DBB LEU PRO GLY GLY GLY GLY VAL CYS DBB SEQRES 2 C 20 LEU DBB DHA GLU CYS ILE TEE SEQRES 1 D 20 CYS DBB PHE DBB LEU PRO GLY GLY GLY GLY VAL CYS DBB SEQRES 2 D 20 LEU DBB DHA GLU CYS ILE TEE SEQRES 1 E 20 CYS DBB PHE DBB LEU PRO GLY GLY GLY GLY VAL CYS DBB SEQRES 2 E 20 LEU DBB DHA GLU CYS ILE TEE SEQRES 1 F 20 CYS DBB PHE DBB LEU PRO GLY GLY GLY GLY VAL CYS DBB SEQRES 2 F 20 LEU DBB DHA GLU CYS ILE TEE MODRES 1QOW DHA A 16 SER 2-AMINO-ACRYLIC ACID MODRES 1QOW DHA B 16 SER 2-AMINO-ACRYLIC ACID MODRES 1QOW DHA C 16 SER 2-AMINO-ACRYLIC ACID MODRES 1QOW DHA D 16 SER 2-AMINO-ACRYLIC ACID MODRES 1QOW DHA E 16 SER 2-AMINO-ACRYLIC ACID MODRES 1QOW DHA F 16 SER 2-AMINO-ACRYLIC ACID HET DBB A 2 6 HET DBB A 4 6 HET DBB A 13 6 HET DBB A 15 6 HET DHA A 16 5 HET TEE A 20 4 HET DBB B 2 6 HET DBB B 4 6 HET DBB B 13 6 HET DBB B 15 6 HET DHA B 16 5 HET TEE B 20 4 HET DBB C 2 6 HET DBB C 4 6 HET DBB C 13 6 HET DBB C 15 6 HET DHA C 16 5 HET TEE C 20 4 HET DBB D 2 6 HET DBB D 4 6 HET DBB D 13 6 HET DBB D 15 6 HET DHA D 16 5 HET TEE D 20 4 HET DBB E 2 6 HET DBB E 4 6 HET DBB E 13 6 HET DBB E 15 6 HET DHA E 16 5 HET TEE E 20 4 HET DBB F 2 6 HET DBB F 4 6 HET DBB F 13 6 HET DBB F 15 6 HET DHA F 16 5 HET TEE F 20 4 HET MOH A 802 2 HET MOH A 804 2 HET MOH A 806 2 HET MOH B 809 2 HET MOH C 807 2 HET MOH D 808 2 HET MOH E 801 2 HET MOH E 805 2 HET MOH F 810 2 HETNAM DBB D-ALPHA-AMINOBUTYRIC ACID HETNAM DHA 2-AMINO-ACRYLIC ACID HETNAM TEE 2-AMINO-ETHENETHIOL HETNAM MOH METHANOL HETSYN DHA 2,3-DIDEHYDROALANINE HETSYN TEE 2-THIOETHENAMINE FORMUL 1 DBB 24(C4 H9 N O2) FORMUL 1 DHA 6(C3 H5 N O2) FORMUL 1 TEE 6(C2 H5 N S) FORMUL 7 MOH 9(C H4 O) FORMUL 16 HOH *57(H2 O) LINK C CYS A 1 N DBB A 2 1555 1555 1.32 LINK SG CYS A 1 CB DBB A 2 1555 1555 1.79 LINK C DBB A 2 N PHE A 3 1555 1555 1.34 LINK C PHE A 3 N DBB A 4 1555 1555 1.32 LINK C DBB A 4 N LEU A 5 1555 1555 1.34 LINK CB DBB A 4 SG CYS A 12 1555 1555 1.81 LINK C CYS A 12 N DBB A 13 1555 1555 1.32 LINK C DBB A 13 N LEU A 14 1555 1555 1.33 LINK CB DBB A 13 SG CYS A 18 1555 1555 1.81 LINK C LEU A 14 N DBB A 15 1555 1555 1.33 LINK C DBB A 15 N DHA A 16 1555 1555 1.33 LINK CB DBB A 15 SG TEE A 20 1555 1555 1.83 LINK C DHA A 16 N GLU A 17 1555 1555 1.36 LINK C ILE A 19 N TEE A 20 1555 1555 1.34 LINK C CYS B 1 N DBB B 2 1555 1555 1.31 LINK SG CYS B 1 CB DBB B 2 1555 1555 1.82 LINK C DBB B 2 N PHE B 3 1555 1555 1.33 LINK C PHE B 3 N DBB B 4 1555 1555 1.34 LINK C DBB B 4 N LEU B 5 1555 1555 1.33 LINK CB DBB B 4 SG CYS B 12 1555 1555 1.81 LINK C CYS B 12 N DBB B 13 1555 1555 1.33 LINK C DBB B 13 N LEU B 14 1555 1555 1.32 LINK CB DBB B 13 SG CYS B 18 1555 1555 1.80 LINK C LEU B 14 N DBB B 15 1555 1555 1.33 LINK C DBB B 15 N DHA B 16 1555 1555 1.33 LINK CB DBB B 15 SG TEE B 20 1555 1555 1.83 LINK C DHA B 16 N GLU B 17 1555 1555 1.35 LINK C ILE B 19 N TEE B 20 1555 1555 1.34 LINK C CYS C 1 N DBB C 2 1555 1555 1.31 LINK SG CYS C 1 CB DBB C 2 1555 1555 1.81 LINK C DBB C 2 N PHE C 3 1555 1555 1.33 LINK C PHE C 3 N DBB C 4 1555 1555 1.32 LINK CB DBB C 4 SG CYS C 12 1555 1555 1.81 LINK C DBB C 4 N LEU C 5 1555 1555 1.33 LINK C CYS C 12 N DBB C 13 1555 1555 1.34 LINK C DBB C 13 N LEU C 14 1555 1555 1.32 LINK CB DBB C 13 SG CYS C 18 1555 1555 1.81 LINK C LEU C 14 N DBB C 15 1555 1555 1.33 LINK C DBB C 15 N DHA C 16 1555 1555 1.33 LINK CB DBB C 15 SG TEE C 20 1555 1555 1.83 LINK C DHA C 16 N GLU C 17 1555 1555 1.34 LINK C ILE C 19 N TEE C 20 1555 1555 1.34 LINK C CYS D 1 N DBB D 2 1555 1555 1.31 LINK SG CYS D 1 CB DBB D 2 1555 1555 1.80 LINK C DBB D 2 N PHE D 3 1555 1555 1.33 LINK C PHE D 3 N DBB D 4 1555 1555 1.33 LINK CB DBB D 4 SG CYS D 12 1555 1555 1.80 LINK C DBB D 4 N LEU D 5 1555 1555 1.34 LINK C CYS D 12 N DBB D 13 1555 1555 1.33 LINK CB DBB D 13 SG CYS D 18 1555 1555 1.82 LINK C DBB D 13 N LEU D 14 1555 1555 1.35 LINK C LEU D 14 N DBB D 15 1555 1555 1.33 LINK CB DBB D 15 SG TEE D 20 1555 1555 1.82 LINK C DBB D 15 N DHA D 16 1555 1555 1.33 LINK C DHA D 16 N GLU D 17 1555 1555 1.31 LINK C ILE D 19 N TEE D 20 1555 1555 1.34 LINK C CYS E 1 N DBB E 2 1555 1555 1.32 LINK SG CYS E 1 CB DBB E 2 1555 1555 1.80 LINK C DBB E 2 N PHE E 3 1555 1555 1.36 LINK C PHE E 3 N DBB E 4 1555 1555 1.33 LINK CB DBB E 4 SG CYS E 12 1555 1555 1.82 LINK C DBB E 4 N LEU E 5 1555 1555 1.34 LINK C CYS E 12 N DBB E 13 1555 1555 1.35 LINK CB DBB E 13 SG CYS E 18 1555 1555 1.80 LINK C DBB E 13 N LEU E 14 1555 1555 1.33 LINK C LEU E 14 N DBB E 15 1555 1555 1.31 LINK C DBB E 15 N DHA E 16 1555 1555 1.34 LINK CB DBB E 15 SG TEE E 20 1555 1555 1.82 LINK C DHA E 16 N GLU E 17 1555 1555 1.33 LINK C ILE E 19 N TEE E 20 1555 1555 1.33 LINK SG CYS F 1 CB DBB F 2 1555 1555 1.79 LINK C CYS F 1 N DBB F 2 1555 1555 1.31 LINK C DBB F 2 N PHE F 3 1555 1555 1.33 LINK C PHE F 3 N DBB F 4 1555 1555 1.32 LINK CB DBB F 4 SG CYS F 12 1555 1555 1.83 LINK C DBB F 4 N LEU F 5 1555 1555 1.33 LINK C CYS F 12 N DBB F 13 1555 1555 1.34 LINK CB DBB F 13 SG CYS F 18 1555 1555 1.81 LINK C DBB F 13 N LEU F 14 1555 1555 1.32 LINK C LEU F 14 N DBB F 15 1555 1555 1.33 LINK CB DBB F 15 SG TEE F 20 1555 1555 1.83 LINK C DBB F 15 N DHA F 16 1555 1555 1.34 LINK C DHA F 16 N GLU F 17 1555 1555 1.33 LINK C ILE F 19 N TEE F 20 1555 1555 1.34 CISPEP 1 CYS A 1 DBB A 2 0 2.72 CISPEP 2 CYS B 1 DBB B 2 0 1.38 CISPEP 3 CYS C 1 DBB C 2 0 1.08 CISPEP 4 CYS D 1 DBB D 2 0 3.20 CISPEP 5 CYS E 1 DBB E 2 0 1.56 CISPEP 6 CYS F 1 DBB F 2 0 2.60 SITE 1 AC1 35 HOH A2001 HOH A2002 HOH A2003 HOH A2004 SITE 2 AC1 35 HOH A2005 HOH A2006 HOH A2007 HOH A2008 SITE 3 AC1 35 HOH A2009 HOH A2010 HOH A2011 HOH A2014 SITE 4 AC1 35 GLY B 7 GLY B 8 GLY B 10 VAL B 11 SITE 5 AC1 35 DHA B 16 GLU B 17 CYS B 18 ILE B 19 SITE 6 AC1 35 HOH B2013 CYS C 1 DBB C 2 PHE C 3 SITE 7 AC1 35 DBB C 4 LEU C 5 GLY C 7 DHA D 16 SITE 8 AC1 35 PHE E 3 DBB E 4 CYS E 12 HOH E2002 SITE 9 AC1 35 VAL F 11 CYS F 12 ILE F 19 SITE 1 AC2 35 DBB A 2 PHE A 3 LEU A 5 GLY A 8 SITE 2 AC2 35 GLY A 10 VAL A 11 LEU A 14 DBB A 15 SITE 3 AC2 35 HOH B2001 HOH B2002 HOH B2003 HOH B2004 SITE 4 AC2 35 HOH B2006 HOH B2007 HOH B2008 HOH B2009 SITE 5 AC2 35 HOH B2010 HOH B2011 HOH B2012 HOH B2013 SITE 6 AC2 35 HOH B2014 PHE C 3 DHA C 16 GLU C 17 SITE 7 AC2 35 CYS C 18 ILE C 19 HOH C2003 DBB D 4 SITE 8 AC2 35 CYS D 12 DHA D 16 HOH D2005 CYS F 1 SITE 9 AC2 35 LEU F 5 GLY F 7 GLY F 8 SITE 1 AC3 20 PHE A 3 GLY A 9 GLY A 10 GLU A 17 SITE 2 AC3 20 CYS A 18 ILE A 19 HOH A2005 HOH A2011 SITE 3 AC3 20 DBB B 2 PHE B 3 LEU B 5 HOH C2001 SITE 4 AC3 20 HOH C2002 HOH C2003 GLY D 8 DBB D 15 SITE 5 AC3 20 DHA D 16 PHE F 3 GLY F 9 CYS F 12 SITE 1 AC4 27 VAL A 11 HOH A2012 DBB B 4 GLY B 8 SITE 2 AC4 27 GLY B 9 CYS B 12 HOH B2004 HOH B2006 SITE 3 AC4 27 GLY C 8 GLY C 10 DHA C 16 HOH D2001 SITE 4 AC4 27 HOH D2002 HOH D2003 HOH D2004 HOH D2005 SITE 5 AC4 27 PRO E 6 GLY E 10 GLU E 17 CYS E 18 SITE 6 AC4 27 ILE E 19 HOH E2008 DBB F 2 PHE F 3 SITE 7 AC4 27 LEU F 5 LEU F 14 HOH F2003 SITE 1 AC5 30 PHE A 3 DBB A 4 CYS A 12 HOH A2003 SITE 2 AC5 30 HOH A2008 HOH A2012 CYS D 1 DBB D 2 SITE 3 AC5 30 PHE D 3 GLY D 7 HOH D2001 HOH E2001 SITE 4 AC5 30 HOH E2002 HOH E2003 HOH E2004 HOH E2005 SITE 5 AC5 30 HOH E2007 HOH E2008 PHE F 3 PRO F 6 SITE 6 AC5 30 GLY F 7 GLY F 8 GLY F 10 VAL F 11 SITE 7 AC5 30 LEU F 14 DHA F 16 GLU F 17 CYS F 18 SITE 8 AC5 30 ILE F 19 HOH F2011 SITE 1 AC6 38 DBB A 13 ILE A 19 HOH A2009 HOH A2013 SITE 2 AC6 38 CYS B 1 DBB B 2 PRO B 6 GLY B 8 SITE 3 AC6 38 HOH B2001 PHE C 3 DBB C 4 DHA C 16 SITE 4 AC6 38 HOH C2002 PHE D 3 LEU D 5 GLU D 17 SITE 5 AC6 38 CYS D 18 ILE D 19 HOH D2005 DBB E 2 SITE 6 AC6 38 PHE E 3 LEU E 5 GLY E 8 GLY E 10 SITE 7 AC6 38 VAL E 11 LEU E 14 DBB E 15 HOH F2002 SITE 8 AC6 38 HOH F2003 HOH F2004 HOH F2005 HOH F2006 SITE 9 AC6 38 HOH F2007 HOH F2008 HOH F2009 HOH F2010 SITE 10 AC6 38 HOH F2011 HOH F2012 CRYST1 46.090 46.090 31.020 90.00 90.00 120.00 P 32 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021697 0.012527 0.000000 0.00000 SCALE2 0.000000 0.025053 0.000000 0.00000 SCALE3 0.000000 0.000000 0.032237 0.00000